TearLab Corporation (TEAR)
(Delayed Data from OTC)
$0.06 USD
0.00 (0.00%)
Updated Jul 9, 2020 09:35 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
TearLab Corporation [TEAR]
Reports for Purchase
Showing records 41 - 60 ( 165 total )
Company: TearLab Corporation
Industry: Medical - Instruments
Objective, Rapid Dry Eye Diagnosis; Initiating Coverage at Buy with $2 Price Target
Provider: H.C. Wainwright & Co., Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
TearLab sees way to profitability, multiple catalysts on horizon, up to STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
1Q Recap - Flex Shows Consistency, Financing Addresses Overhang
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
TearLab pre-released Q1 sales ahead of estimates despite disruptions, reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
Q4 inline, pleased with restructuring details, waiting on financing, reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Updating Model for Prelim. 4Q / 2016 Guidance and Restructuring
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
American Academy of Ophthalmology 2015 Recap, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
Q3 sales topped our estimates on strong international sales
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
First Coast LCD Removes Reimbursement Uncertainty
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
Healthcare - 3Q 2015: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C